Project Grant R01DA064130
- The U.S. National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $686,692 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Medical University of South Carolina. The grant will fund an 8-week clinical trial to assess the prospective changes in patient-reported and objective functioning following reduction of cannabis use among adults with cannabis use disorder. The trial will evaluate the benefits of cannabis harm...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This federal Project Grant award for $395,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a 5-year prospective study to investigate the bidirectional relationship between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis in 60 participants aged 21-29 years, including healthy controls, moderate cannabis users, and those...
- This $507,000.00 federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research at the Icahn School of Medicine at Mount Sinai to investigate the epigenetic mechanisms underlying cannabis use disorder. The project, running from September 1, 2025 to May 31, 2030, aims to leverage a translational animal model of voluntary THC consumption to study sex differences and individual variability in...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, supports a $197,024 study titled "Bridging the Gap: Understanding Clinician Stigma in Buprenorphine Prescribing and Its Influence on Treatment Decisions and Patient Perspectives in the Veterans Health Administration" (CFDA 93.279 - Drug Use and Addiction Research Programs). The study aims to conduct mixed-methods analyses using secondary data, including...
- This $189,500.00 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The project aims to determine the extent to which cardiovascular disease (CVD) affects people with opioid use disorder (OUD) and identify ways to prevent CVD in this population. To achieve this, the project will: 1) Examine the relationship between CVD and OUD using Transformed...
- The National Institute on Drug Abuse (NIDA), through the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $684,694 Cooperative Agreement to New York University (NYU) to develop and evaluate a novel home-based intervention combining transcranial direct current stimulation (tDCS) with mindfulness meditation for the treatment of cannabis use disorder (CUD). The project, titled "Telehealth-Delivered tDCS for Cannabis Addiction Recovery: The C.A.R.E.S. (Cannabis Addiction...
- This federal Project Grant award of $158,246.00 from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will support research under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will fund a comprehensive, longitudinal study investigating the co-occurrence of trauma, substance use, and additional stressors among Americans from childhood through adulthood. The research aims to elucidate the etiological trajectories of co-occurring...
- This Project Grant award of $153,000.00, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a 6-month longitudinal study examining the relationships between naturalistic cannabis use, pain perception, and functioning (e.g., pain-related disability, physical activity, sleep) in the daily lives of young adults with chronic pain. The study will use an ecological momentary assessment burst design to capture...
- This four-year, $4.6 million project grant from the National Institute on Drug Abuse will fund research at the University of Miami exploring the linkage between cannabis use, route of administration, cannabinoid content, and measures of cardiovascular disease (CVD) risk in people living with HIV (PWH). Specifically, the principal investigator - an interventional cardiologist and physician scientist focused on HIV and CVD prevention - will collect comprehensive data on 300 PWH ages 18-60 to...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), will support a longitudinal study on the impact of cannabis use disorder (CUD) and its treatment on opioid-related health consequences among patients in the Veterans Health Administration (VHA) system. The $744,875 award, to be provided from September 15, 2025 through May 31, 2030, will enable researchers at the Trustees of Columbia University in the City of New York to examine associations between CUD, opioid use disorder (OUD), opioid-related hospitalizations, and fatal/non-fatal overdoses. The study will also assess whether receipt of CUD treatment reduces these risks among VHA patients, an important population given the high co-occurrence of CUD and OUD observed in preliminary data. The findings from this comprehensive longitudinal investigation have the potential to inform clinical practices and policy decisions aimed at addressing the intersection of the opioid crisis and cannabis use in the veteran population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $744.9k | 9/12/25 |